VanEck Israel ETF (ISRA) ETF Analysis
The VanEck Israel ETF (ISRA) offers investors exposure to Israeli equities, seeking to replicate the BlueStar Israel Global Index. With an AUM of $0.14 billion, ISRA provides a focused approach to investing in Israeli companies.
The ETF's expense ratio is 0.71%. ISRA's top holdings include Teva Pharmaceutical Industries Ltd ADR and major Israeli banks, making it a targeted play on the Israeli economy.
VanEck Israel ETF (ISRA) ETF — Price, Holdings & Analysis
ETF Overview
Risk Metrics
Expense Ratio
What does ISRA hold?
How Is the Fund Allocated?
| Sector | Weight |
|---|---|
| Financial Services | 38.5% |
| Technology | 21.7% |
| Healthcare | 12.2% |
| Industrials | 10.8% |
| Real Estate | 4.7% |
| Utilities | 4.5% |
| Consumer Cyclical | 2.0% |
| Energy | 2.0% |
| Communication Services | 1.9% |
| Consumer Defensive | 1.6% |
| Basic Materials | 0.2% |
| Country | Weight |
|---|---|
| Israel | 91.1% |
| United States | 7.9% |
| United Kingdom | 0.4% |
| Singapore | 0.3% |
| Jersey | 0.2% |
| Other | 0.1% |
Dividend Yield
- Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
- State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio
- State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
- State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
- iShares Russell 2000 ETF (IWM) — 0.19% expense ratio
- State Street Financial Select Sector SPDR ETF (XLF) — 0.08% expense ratio
- iShares MSCI Emerging Markets ETF (EEM) — 0.72% expense ratio
- State Street SPDR S&P 500 ETF (SPY) — 0.09% expense ratio
- VanEck Uranium and Nuclear ETF (NLR) (Equity) — 0.56% expense ratio
- VanEck Junior Gold Miners ETF (GDXJ) (Equity) — 0.51% expense ratio
- VanEck Gold Miners ETF (GDX) (Equity) — 0.51% expense ratio
- VanEck Emerging Markets High Yield Bond ETF (HYEM) (Multi-Asset) — 0.40% expense ratio
- VanEck Green Infrastructure ETF (RNEW) (Equity) — 0.47% expense ratio
- VanEck Technology TruSector ETF (TRUT) (Equity) — 0.14% expense ratio
Risk Metrics
- Beta: 1.18
Questions & Answers
What is ISRA and what does it track?
The VanEck Israel ETF (ISRA) seeks to replicate the price and yield performance of the BlueStar Israel Global Index. This index is composed of equity securities of publicly traded companies that are generally considered to be Israeli companies.
What is the expense ratio for ISRA?
The expense ratio for the VanEck Israel ETF (ISRA) is 0.71%. This means that for every $10,000 invested in the fund, $71 is used to cover the fund's operating expenses.
While this provides access to a specific market, it is important to consider the cost relative to potential returns.
What are the top holdings in ISRA?
As of 2026-03-15, the top holdings in the VanEck Israel ETF (ISRA) are: Teva Pharmaceutical Industries Ltd ADR, with a weight of 11.43%; Bank Leumi Le-Israel BM, at 9.26%; Bank Hapoalim BM, comprising 8.13%; Elbit Systems Ltd at 6.50%; and…
Check Point Software Technologies Ltd, making up 3.64% of the fund.
Is ISRA a good long-term investment?
Whether ISRA is a suitable long-term investment depends on an individual's investment goals, risk tolerance, and outlook on the Israeli economy. ISRA provides targeted exposure to Israeli equities, which can offer diversification benefits.
However, it also carries concentration risk due to its focus on a single country.
How does ISRA compare to similar ETFs?
ISRA stands out with its specific focus on Israeli equities. While other regional or global ETFs may include some Israeli companies, ISRA offers a more concentrated exposure.
With an expense ratio of 0.71% and AUM of $0.14 billion, ISRA's expense ratio may be higher than broader market ETFs.
Does ISRA pay dividends?
As of 2026-03-15, the VanEck Israel ETF (ISRA) has a dividend yield of 0.00%. This indicates that the fund is not currently distributing dividends to its shareholders.
Investors seeking income-generating investments may need to consider other ETFs with a history of dividend payments. The lack of a dividend yield may be a factor for investors prioritizing current income over capital appreciation.